2-240873022-G-C
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS1_ModeratePM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000030.3(AGXT):c.568G>C(p.Gly190Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G190E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000030.3 missense
Scores
Clinical Significance
Conservation
Publications
- alanine glyoxylate aminotransferase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- primary hyperoxaluria type 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000030.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AGXT | NM_000030.3 | MANE Select | c.568G>C | p.Gly190Arg | missense | Exon 5 of 11 | NP_000021.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AGXT | ENST00000307503.4 | TSL:1 MANE Select | c.568G>C | p.Gly190Arg | missense | Exon 5 of 11 | ENSP00000302620.3 | ||
| AGXT | ENST00000472436.1 | TSL:2 | n.588G>C | non_coding_transcript_exon | Exon 5 of 5 | ||||
| AGXT | ENST00000476698.1 | TSL:5 | n.305G>C | non_coding_transcript_exon | Exon 2 of 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Primary hyperoxaluria Pathogenic:1
Variant summary: AGXT c.568G>C (p.Gly190Arg) results in a non-conservative amino acid change located in the Aminotransferase class V domain (IPR000192) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249624 control chromosomes (gnomAD). c.568G>C has been reported in the literature in multiple individuals affected with Primary Hyperoxaluria Type 1 (example: Talati_2018). These data indicate that the variant is very likely to be associated with disease. Additionally, a different variant resulting in the same amino acid change (c.568G>A, p.Gly190Arg) has been reported in 19 homozygous cases (PMID: 27935012) and is classified pathogenic in ClinVar ( CV ID 189047). The following publication has been ascertained in the context of this evaluation (PMID: 28660284). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at